MedPath

Evaluation of the Effect of Betamethasone on Neonatal Outcomes in Pregnancies

Phase 2
Conditions
Condition 1: Respiratory Distress Syndrome of Newborn. Condition 2: Preterm Labour and Delivery.
Hyaline Membrane Disease
Onset (Spontaneous) of Labour Before 37 Completed Weeks of Gestation
Registration Number
IRCT2014102919037N2
Lead Sponsor
Investigator
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
140
Inclusion Criteria

Pregnant women aged between 18 to 39 years who are candidate for delivery in 34-36th week of gestational age
Exclusion criteria:
Delivery after 37th week of gestational age; diabetes; fetal anomalies; delivery before receiving the two doses of the drug; multiple pregnancy

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Occurrence of respiratory distress syndrome of newborn. Timepoint: Every 30 min up to 48 h. Method of measurement: Questionnaire.;Apgar. Timepoint: At birth. Method of measurement: Checklist.
Secondary Outcome Measures
NameTimeMethod
eed for newborn admission. Timepoint: Up to 48 h. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath